Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Adoption of electronic health record (EHR)-based clinical decision support tools in community-based health centers might increase the provision of indicated cancer screening orders. We examined: (1) if the use of the care gaps smartset (CGS), an EHR tool that expedites ordering care, is associated with colorectal/cervical cancer (CRC/CVC) screening order rates; and (2) how selected implementation strategies, barriers, and facilitators impact CGS use.Within a sequential mixed methods design, we used multivariate regression to assess associations between clinic- and provider-level CGS use and cancer screening order rates. Tool use rates (3/2018-12/2023) were measured as the rate of encounters at which any orders were placed via the CGS and then categorized by use level. Surveys ( = 81) and semi-structured interviews ( = 11) with clinic staff assessed strategies to improve tool use.Clinics and providers that ever used the CGS had higher CRC screening order rates than non-users. Higher CGS use was associated with better CRC screening order rates. By 12/2023, CRC screening orders were 4.4% ( < 0.05) higher in high-use clinics versus those with no CGS use. CGS use was not associated with CVC screening order rates. Qualitative findings indicate effective CGS use was enhanced by leadership support, clear workflows, and clinic-led training. Barriers to CGS use included low user awareness of/trust in the tool, and tool functions that were not optimized.CGS use can support cancer screening ordering; its adoption may be enhanced by varied training approaches and workflow design.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137202PMC
http://dx.doi.org/10.1055/a-2524-5076DOI Listing

Publication Analysis

Top Keywords

screening order
20
order rates
20
cancer screening
12
crc screening
12
community-based health
8
health centers
8
screening orders
8
screening
7
rates
6
cgs
6

Similar Publications

Type 1 diabetes (T1D) is an autoimmune chronic disease that leads to the destruction of pancreatic beta cells and thus requires lifelong insulin therapy. Constraints and adverse events associated to insulin therapy are well known as well as the risk of long-term complications linked to chronic hyperglycaemia. Symptomatic T1D is preceded by a preclinical asymptomatic period, which is characterized by the presence of at least two auto-antibodies against beta cell without disturbances of blood glucose control (stage 1) or, in addition to immunological biomarkers, by the presence of mild dysglycaemia reflecting a defect of early insulin secretion (stage 2).

View Article and Find Full Text PDF

Inflammatory gene expression profile of oral plasmablastic lymphoma.

Virchows Arch

September 2025

Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Minas Gerais, Av. Antônio Carlos, Pampulha, Belo Horizonte, 31270-901, Brazil.

Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma with a poor prognosis and short survival rates. It is classified as a large B-cell lymphoma subtype, but carries a plasmacytic immunophenotype. Therefore, PBL has pathogenetic overlaps with diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) and plasma cell neoplasms (PCNs).

View Article and Find Full Text PDF

Background: Sub-Saharan Africa (SSA) bears the highest global burden of cervical cancer. Living with the disease is a complex experience, leading to significant changes across various biopsychosocial dimensions, which in turn affect the quality of life of affected women.

Aims: This review aimed to synthesize available scientific evidence on the life experiences of women diagnosed with cervical cancer in SSA in order to generate valuable insights into the care of the affected population.

View Article and Find Full Text PDF

In this study, employing a 2D electrodeposition in situ assembly method, a high-performance HS sensor based on a p-n type CuO-CuFeO heterostructure ordered nanowire arrays was successfully fabricated on silicon substrates. Compared to CuO, CuO-CuFeO nanowire arrays exhibits an ideal interfacial barrier structure and higher initial resistance, with a response to 10 ppm of HS at room temperature (20 ± 3 °C) increased by 225 times and a response time reduced by over 2400 s. The sensor demonstrates exceptional sensitivity (LOD = 10 ppb; response = 234.

View Article and Find Full Text PDF

Objective: to analyze predictors of inadequacy of prenatal care among postpartum women in a maternity hospital in Brazil.

Methods: cross-sectional study conducted from March 2020 to January 2021 with postpartum women from a maternity hospital in Brazil. Statistical analysis was performed using Pearson's chi-squared test and Poisson regression.

View Article and Find Full Text PDF